These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Acute otitis media caused by Moraxella catarrhalis: epidemiologic and clinical characteristics. Broides A; Dagan R; Greenberg D; Givon-Lavi N; Leibovitz E Clin Infect Dis; 2009 Dec; 49(11):1641-7. PubMed ID: 19886799 [TBL] [Abstract][Full Text] [Related]
43. Isolation of Moraxella catarrhalis in patients at King Khalid University Hospital, Riyadh. Babay HA Saudi Med J; 2000 Sep; 21(9):860-3. PubMed ID: 11376364 [TBL] [Abstract][Full Text] [Related]
45. Changes in nasopharyngeal flora during otitis media of childhood. Faden H; Stanievich J; Brodsky L; Bernstein J; Ogra PL Pediatr Infect Dis J; 1990 Sep; 9(9):623-6. PubMed ID: 2122410 [TBL] [Abstract][Full Text] [Related]
46. Seasonal distribution of otitis media pathogens among Costa Rican children. Guevara S; Soley C; Arguedas A; Porat N; Dagan R Pediatr Infect Dis J; 2008 Jan; 27(1):12-6. PubMed ID: 18162931 [TBL] [Abstract][Full Text] [Related]
47. [Moraxella catarrhalis as an important etiologic factor in infection of the lower bronchial tree]. Nowak-Sadzikowska J; Heczko PB Pneumonol Alergol Pol; 1994; 62(9-10):530-2. PubMed ID: 7866327 [TBL] [Abstract][Full Text] [Related]
48. A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges. Perez AC; Murphy TF Hum Vaccin Immunother; 2017 Oct; 13(10):2322-2331. PubMed ID: 28853985 [TBL] [Abstract][Full Text] [Related]
49. β-Lactamase production and antibiotic susceptibility pattern of Moraxella catarrhalis isolates collected from two county hospitals in China. Shi W; Wen D; Chen C; Yuan L; Gao W; Tang P; Cheng X; Yao K BMC Microbiol; 2018 Jul; 18(1):77. PubMed ID: 30029595 [TBL] [Abstract][Full Text] [Related]
54. [Invasive infection with Moraxella catarrhalis in two children with lymphatic leukemia and granulocytopenia]. Ernst-Kruis MR; Rutgers MI; Révész T; Wolfs TF; Fleer A; Geelen SP Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1126-8. PubMed ID: 12822523 [TBL] [Abstract][Full Text] [Related]
55. Branhamella catarrhalis in acute otitis media. Karma P; Virtanen T; Pukander J; Sipilä M; Luotonen J; Timonen M; Herva E; Grönroos P Acta Otolaryngol; 1985; 99(3-4):285-90. PubMed ID: 3874516 [TBL] [Abstract][Full Text] [Related]
56. Branhamella catarrhalis septicemia in an immunocompetent adult. Alaeus A; Stiernstedt G Scand J Infect Dis; 1991; 23(1):115-6. PubMed ID: 1902980 [TBL] [Abstract][Full Text] [Related]
57. Antibody response to P-protein in patients with Branhamella catarrhalis infections. Chi DS; Verghese A; Moore C; Hamati F; Berk SL Am J Med; 1990 May; 88(5A):25S-27S. PubMed ID: 2111089 [TBL] [Abstract][Full Text] [Related]
58. Comparison of the local immune response to nontypable Haemophilus influenzae (nHI) and Moraxella catarrhalis (MC) during otitis media. Faden H Adv Exp Med Biol; 1995; 371B():733-6. PubMed ID: 7502887 [No Abstract] [Full Text] [Related]
59. Branhamella infections. An increasingly common respiratory illness. Feleke G; Khan FA Postgrad Med; 1989 Mar; 85(4):379-86. PubMed ID: 2494649 [TBL] [Abstract][Full Text] [Related]
60. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections. Slevin NJ; Aitken J; Thornley PE Lancet; 1984 Apr; 1(8380):782-3. PubMed ID: 6143094 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]